The largest database of trusted experimental protocols

5 protocols using brefeldin a and monensin

1

Restimulation of Tumor-Draining Lymph Nodes

Check if the same lab product or an alternative is used in the 5 most similar protocols
All cells from each individual tumor-draining lymph node (dLN) or 106 total splenocytes were plated in 2 mL media and restimulated with PMA (250 ng/mL) and ionomycin (1 μM) in the presence of monensin and brefeldin A (Biolegend). After three hours, the cells were washed and permeabilized before being stained for intracellular IFNγ for flow cytometry.
+ Open protocol
+ Expand
2

Evaluating Antigen-Specific T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proliferation assays were performed in 96‐well U‐bottom plates (Greiner Bio‐One). BMDCs (pulsed with or without lysates) were co‐cultured with 105 CD3+ cells at different ratios (1:1, 10:1, and 100:1 CD3:BMDC) in RPMI 1640 medium as described above. The CD3+ cells were previously labeled with CellTrace Violet per the manufacturer's directions (Thermo Fisher Scientific). After 6 days of co‐culture, flow cytometry was used to measure CD3+ T‐cell proliferation. Supernatants were collected from cells co‐cultured for 24 h, and assayed by ELISA for interferon‐γ (Legend Max, BioLegend™).
Cytotoxicity assays were performed using 105 rat splenic CD3+ cells co‐cultured in 96‐well U‐bottom plates with 104 BMDCs in RPMI 1640, supplemented as described above. On day 7, the CD3+ cells were collected and incubated for 18 h in flat‐bottom 96‐well plates, along with target cells, at effector‐to‐target ratios ranging from 20:1 to 0.625:1. The plates were assayed for lysis by LDH assay (Thermo Scientific Pierce). CD107a expression was measured essentially as described by Betts et al (2003). BMDCs were added to CD3+ cells, co‐cultured for 1 h in the presence of CD107a antibody, and incubated for another 5 h in the presence of monensin and brefeldin A (BioLegend). The cells were fixed and stained with anti‐CD4, anti‐CD8, and secondary to CD107a antibodies and analyzed by flow cytometry.
+ Open protocol
+ Expand
3

Vac-OVA Infection and LPS Treatment in Infant Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fifteen-day-old CTRL and MAT C57BL/6J infant mice were infected with Vac-OVA (1 × 104 PFU i.p.) and orally treated with E. coli 0111:B4-derived LPS (50 μg orogastric; InvivoGen) beginning on the day of the infection and continuing every other day for 10 days. Mice were monitored daily for weight loss and appearance of illness. Eleven days after infection, mice were euthanized by CO2 inhalation. Spleens were mechanically disrupted to obtain single cell suspensions and then treated with ACK buffer to lyse red blood cells. For the detection of cytokines, the splenocytes were cultured for 5 h in RPMI-10 with SIINFEKL peptide (5 μM; New England Peptide), phorbol 12-myristate 13-acetate (PMA) (10 ng/ml), and ionomycin (1 μg/ml) in the presence of brefeldin A and monensin (BioLegend).
+ Open protocol
+ Expand
4

Measuring Th1 Differentiation and EBV-specific Effector T Cell Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Th1 differentiation was assessed by co-culture of sorted naive CD4+ T cells and infected B cells 5 dpi. 1 × 105 naive CD4+ T cells stained with CellTrace Violet (Thermo Fischer Scientific) and 0.5 or 1 × 105 infected B cells were cultured in 96-well plates with Dynabeads Human T-Activator CD3/CD28 (Thermo Fischer Scientific) and cultivated for 7 d. The neutralizing antibody against IL12B (C8.6; BioLegend) or the corresponding isotype control antibody (MOPC-21; BioLegend) were added for certain experiments at 5 µg/ml. Cells were restimulated with PMA and ionomycin (Cell Stimulation Cocktail; eBioscience) for 5 h and treated with Brefeldin A and Monensin (BioLegend) for 2.5 h before fixation. Th1 population was measured by intracellular IFN-γ staining with FIX and PERM Cell Fixation and Cell Permeabilization kit (Thermo Fischer Scientific) and subsequent flow cytometry analysis. The Th1 population was defined as IFN-γ+ T cells in the fraction of proliferating T cells identified via CellTrace Violet staining. EBV-specific effector T cells’ activities were measured with ELISA and Calcein release assays. For IFN-γ detection from T cells, effector and target cells were seeded at 5 × 104 cell per ml (1:1 ratio) each and co-cultured for 16 h in a 96-well plate (V bottom). IFN-γ levels were detected with ELISA. IFN-γ concentrations <16 pg/ml were considered as not detected.
+ Open protocol
+ Expand
5

Cytokine Analysis of Stimulated Lung Leukocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lung leukocytes were stimulated with plate bound anti-CD3 and anti-CD28 antibodies (2.5μg/ml) in 96 well plates (2.5×106/well) for a total of 6 hours, with Brefeldin A and monensin (Biolegend) added during the last 4 hours. Cells were washed in PBS then stained Live Dead Fixable Aqua (Life Technologies) and anti-CD45 (clone 30-F11), anti-TCRβ (clone H57-597), anti-CD8α (53-6.7), and anti-CD4 (clone GK1.5) antibodies (Biolegend), washed, then fixed in 2% formaldehyde. Intracellular cytokines were detected by staining with anti-IFN-γ (clone XGM1.2), anti-IL-17A (TC11-18H10.1), anti-IL-5 (TRFK5), anti-IL-13 (eBio13A), Tbet (4B10), GATA3 (16E10A23), FoxP3 (FJK-16s) and Eomesodermin (Dan11mag, eBioscience) antibodies in Permeabilzation Buffer (eBioscience). Data were acquired on a LSRII cytometer and analyzed with FlowJo (Treestar, Eugene Oregon). A representative gating scheme is shown in Fig. S1A.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!